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Abstract
The membrane associated guanylate kinase (MAGUK) family member, human Discs Large 1 (hDlg1) uses a PDZ domain array
to interact with the polarity determinant, the Adenomatous Polyposis Coli (APC) microtubule plus end binding protein. The
hDLG1-APC complex mediates a dynamic attachment between microtubule plus ends and polarized cortical determinants
in epithelial cells, stem cells, and neuronal synapses. Using its multi-domain architecture, hDlg1 both scaffolds and regulates
the polarity factors it engages. Molecular details underlying the hDlg1-APC interaction and insight into how the hDlg1 PDZ
array may cluster and regulate its binding factors remain to be determined. Here, I present the crystal structure of the hDlg1
PDZ2-APC complex and the molecular determinants that mediate APC binding. The hDlg1 PDZ2-APC complex also provides
insight into potential modes of ligand-dependent PDZ domain clustering that may parallel Dlg scaffold regulatory
mechanisms. The hDlg1 PDZ2-APC complex presented here represents a core biological complex that bridges polarized
cortical determinants with the dynamic microtubule cytoskeleton.
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Introduction
Cell polarity is a core, biological process requisite for cell
division, chemotaxis and multi-cellular development. Polarity
factors integrate cellular cues and translate these signals into
directed cytoskeletal change. This requires an interplay between
polarity determinants and the cytoskeleton, an association that is
inherently complicated by membrane and cytoskeletal dynamics.
To stably link cortical determinants with the dynamic cytoskele-
ton, a bridge must be established that retains membrane
association while sustaining a static or processive cytoskeletal
attachment. One example of a molecular bridge between the
membrane and the microtubule cytoskeleton is the complex
formed between Dlg1 and APC, a protein that binds polymerizing
microtubule plus ends in an EB1-dependent manner [1,2,3,4,5,6].
Dlg1 is a MAGUK protein family member localized to
polarized structures including epithelial junctions, stem cell
cortical regions, and neuronal synapses [7,8,9,10]. MAGUK
proteins adhere to a common domain architecture comprising one
to three PDZ domains that bind target proteins, an SH3 domain,
a variable HOOK sequence, and an enzymatically inactive
guanylate kinase domain (Figure 1A) [11,12,13]. Collectively,
MAGUK protein domains operate as scaffolding that actively
cluster and regulate the components they bind. Canonical PDZ-
protein interactions involve PDZ domain binding to a target
protein’s C-terminal region [14]. PDZ domains are classified
based on the target sequences they bind. Common PDZ targets
are classified as type I: -S/T-X-Q, type II: -Q-X-Q, or type III: -D/
E-X-Q motifs where Q is a valine or leucine. Dlg1 contains three
PDZ domains, classified as G-H PDZ domains with specificity for
type I PDZ-binding motifs [15]. PDZ1 and PDZ2 directly abut
each other while a 49 amino acid linker bridges PDZ2 and PDZ3.
Intra-molecular PDZ domain interactions have been observed in
ligand-free PDZ domain-containing proteins including PSD-95,
GRIP, and syntenin [16,17,18,19,20,21]. Additional studies have
demonstrated ligand-dependent changes in intra-molecular PDZ
domain interactions, specifically, the release of PDZ interactions
upon ligand binding [22]. But how PDZ domain arrays promote
target clustering remains an outstanding question. PDZ-mediated
clustering enables the MAGUK proteins to coordinate and
modulate signaling and cytoskeletal components in space and
time. Mapping the diverse modes PDZ domains use to bind target
proteins and interact with neighboring PDZ domains is funda-
mental to understanding how MAGUK proteins operate. Factors
found to bind the Dlg1 PDZ domains include the Ca2+pump 4b,
p56lck tyrosine kinase, human papillomavirus E6 protein, and the
polarity determinant APC [1,23,24,25]. Dlg1 is competent to bind
the APC C-terminus using either PDZ1 or PDZ2. The APC C-
terminus is a type I PDZ binding motif that binds Dlg1 PDZ1 and
PDZ2 with 18 mM and 1 mM affinity, respectively [26].
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APC is a conserved, multi-domain, multi-motif scaffolding
protein involved in b-catenin destruction, cell adhesion, microtu-
bule dynamics, and cytoskeletal signaling [27,28,29,30,31,32,33].
Mutations in APC have pleotropic effects including aberrant wnt
signaling, defects in cell adhesion and adherens junction structure,
developmental defects, and colorectal cancer [34,35]. Underlying
its multifunctional cellular role is its diverse domain architecture
that spans 2843 amino acids. Central motifs, designated 15 and 20
amino acid repeats and SAMP motifs are determinants that bind
wnt signaling components and orchestrate b-catenin destruction
[36,37]. Delineated cytoskeletal binding determinants flank the
central motifs involved in wnt-signaling. An N-terminal armadillo
repeat domain binds to cytoskeletal and signaling components
including the kinesin KAP3, the guanine nucleotide exchange
factor ASEF, and the GTPase-activating protein IQGAP
[33,38,39]. The APC C-terminus contains a basic region that
binds microtubules as well as a SxIP-motif that binds the
microtubule plus end tracking protein EB1, localizing APC to
the polymerizing microtubule plus end [40,41,42]. The APC SxIP
motif is 30 amino acids N-terminal to the Dlg1 PDZ-binding motif
(Figure 1B).
The microtubule cytoskeletal array is polarized, with minus
ends predominantly focused at a microtubule organizing center.
Microtubule plus ends fan out towards the cell periphery and are
the focal points of microtubule dynamic instability [43]. Accord-
ingly, a host of factors associate with the microtubule plus end to
regulate its dynamics. A prime factor associated with the
polymerizing microtubule plus end is EB1 [4]. The EB1 N-
terminal calponin homology domain recognizes the GTP state of
the polymerizing microtubule, thereby binding microtubule lattice
determinants specific to the polymerizing tip [44,45]. The
conserved EB1 C-terminal dimerization domain recruits numer-
ous proteins to the microtubule lattice by binding a short amino
acid motif termed a SxIP motif [42]. SxIP motif-containing
proteins are functionally diverse, and include polarity determi-
nants, cytoskeletal crosslinkers, signaling molecules and regulators
of microtubule dynamics. The adenomatous polyposis coli (APC)
tumor suppressor has a C-terminal SxIP motif that affords EB1-
dependent APC microtubule plus end tracking activity. Serendip-
itously, EB1 was first identified in a yeast two-hybrid screen for
APC binding proteins, and was named EB1 to reflect its ability to
bind the end of APC; subsequently it was identified as
a microtubule plus end binding protein [3,4].
Collectively, the Dlg1-APC-EB1 complex mediates a dynamic
link between polarized membrane regions and the microtubule
cytoskeleton [2,6]. APC can use its basic region to bind
microtubules directly, or its SxIP motif to bind EB1, which
localizes it to the polymerizing microtubule plus end. The high-
affinity Dlg1-APC link is mediated by PDZ2. While high-
resolution structural information is available for the Dlg1 PDZ1-
APC interaction, only a partially occupied Dlg1 PDZ2-APC
structure has been determined that showed a splayed APC
peptide, engaging PDZ2 using only its ultimate four residues [26].
When compared to the Dlg1 PDZ1-APC structure that binds the
ultimate five APC residues, the PDZ2-APC structure raised
questions as to why the PDZ2-APC interaction was an order of
magnitude greater than the PDZ1-APC interaction. Here I report
the crystal structure of the Dlg1 PDZ2-APC complex determined
to a resolution of 2.0 Å. This structure shows an extensive
interaction between PDZ2 and APC that spans the ultimate six
APC residues and highlights additional binding determinants that
likely promote the PDZ2-APC interaction. This structure provides
molecular details on the Dlg1-APC polarity complex as well as
determinants that may underlie MAGUK protein dynamic
scaffolding and target clustering.
Materials and Methods
Cloning and Purification
DNA encoding human Dlg1 PDZ2, residues 310–407, was
generated by PCR sewing using oligonucleotide templates with
optimal E. coli codon usage. The Dlg1 PDZ2 fragment was
inserted into pGEX-2T (GE Healthcare) forming a thrombin-
cleavable, N-terminal GST fusion construct. BL21 DE3 pLysS E.
coli were transformed with pGEX-2T-Dlg1 PDZ2, grown in LB
media under 50 mg/L ampicillin selection at 37uC to an optical
density at 600 nm of 1.0 at which point protein expression was
induced by the addition of 0.1 mM isopropyl-1-thio-b-D-galacto-
pyranoside (final concentration), the temperature was lowered to
20uC, and induction proceeded for 16 hours. Cells were harvested
by centrifugation at 21006g for 10 minutes and resuspended in
200 mL buffer A: 25 mM Tris pH 8.0, 300 mM NaCl, 0.1% b-
mercaptoethanol, and lysed by iterative rounds of sonication at
4uC followed by sample cooling. 0.2 mM phenylmethylsulfonyl
fluoride (final concentration) was added during sonication and the
lysate clarified by centrifugation at 23,0006g for 45 min. The
supernatant was loaded onto a 10 ml Glutathione Sepharose Fast
Flow affinity column (GE Healthcare). GST-Dlg1 PDZ2 was
eluted from the glutathione column with 50 ml of 25 mM
glutathione pH 8.0 in buffer A. 1 mM CaCl2 was added to the
eluate, as was 25 mL of a 1 mg/mL thrombin stock (Heamatologic
Technologies) to cleave GST from Dlg1 PDZ2, leaving an N-
terminal gly-ser cloning artifact on the PDZ2 domain. Proteolysis
proceeded for 12 hours at 4uC. Thrombin was removed from the
sample by filtering the sample over 0.5 mL Benzamidine
Sepharose (GE Healthcare). The sample was exchanged into
100 mL buffer B (25 mM HEPES, pH 6.8 and 0.1% b-
mercaptoethanol) using an Amicon Ultra 3 kDa spin concentrator
(Millipore) and loaded onto a 10 mL SP Sepharose Fast Flow
column (GE Healthcare) and eluted using a linear 0–1 M NaCl
gradient in buffer B. Dlg1 PDZ2 peak fractions were pooled and
exchanged into 100 mM NaCl, 25 mM Tris pH 7.0, and 0.1% b-
mercaptoethanol using an Amicon Ultra 3 kDa spin concentrator
(Millipore), concentrated to 25 mg/mL, snap frozen in liquid
Figure 1. Overall structure of the Dlg1 PDZ2-APC complex. A) Domain arrangement of H.s. Dlg1. Shown is the L27 domain (grey), PEST motif
(red), PDZ domains 1–3 (green), SH3 (dark blue), and guanylate kinase domain (orange). B) Domain arrangement of H.s. APC. Shown is the
oligomerization domain, the armadillo repeat domain, 15 and 20 aa repeat sequences used in b-catenin binding, SAMP motifs used for axin binding,
a basic region with microtubule binding activity, and C-terminal EB1 and Dlg1 binding sites. The C-terminal region is boxed and corresponding
sequence shown below. Highlighted in red is the SxIP motif and flanking residues that bind the microtubule plus end tracking protein EB1. The C-
terminal six residues that bind Dlg1 PDZ2 are highlighted in purple. The APC peptide synthesized in this study is indicated by an underline. C) Zoom
view of the APC peptide bound to hDlg PDZ2. Final, refined 2Fo-Fc electron density around the APC peptide is displayed and contoured at 1.0 s. D)
2u structure topology of Dlg1 PDZ2 complexed with the C-terminal APC b-strand (grey), which runs anti-parallel to Dlg1 PDZ2 bB and parallel to aB. E)
Ribbon diagram of Dlg1 PDZ2 complexed with the APC C-terminal six residues shown in stick format. F) Structure shown in E, rotated 45u about the
y-axis. The Dlg b-strands are colored in a yellow to dark green continuum, loop regions are colored orange, helices aA and aB are colored slate and
purple respectively, and the APC peptide is colored grey (C–F).
doi:10.1371/journal.pone.0050097.g001
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nitrogen and stored at 280uC. All purification procedures were
executed at 4uC.
Synthesis of the APC C-terminal Peptide
An APC C-terminal peptide encompassing residues
RHSGSYLVTSV (2833–2843) was synthesized with an N-
terminal tetramethyl rhodamine (TMR) tag by the Yale Keck
Biotechnology Resource Laboratory, purified by HPLC and
verified by mass spectrometry.
Crystallization
1.4 mM Dlg1 PDZ2 was incubated with 1.7 mM APC C-
terminal peptide in 100 mM NaCl, 25 mM Tris, pH 7.0, and
0.1% b-mercaptoethanol for one hour on ice. Crystallization
followed the hanging drop protocol using 2 mL of the Dlg1 PDZ2-
APC mixture and 2 mL of a 1 mL well solution containing
200 mM sodium acetate, 100 mM sodium cacodylate pH 6.25,
28% (w/v) polyethylene glycol 8000. Thin crystal sheets grew at
20uC to dimensions of 2061006600 mm over the course of a week.
Crystals displayed an enhanced red color relative to the
surrounding solution, indicative of TMR-APC peptide incorpora-
tion into the crystals. Crystals were transferred to cryoprotectant
containing well solution supplemented with 30% glycerol and flash
frozen in liquid nitrogen.
Data Collection, Structure Determination, and
Refinement
Dlg1 PDZ2-APC crystals were maintained at 100 K under
a cryo-cooled nitrogen stream and diffraction data collected at the
Advanced Light Source synchrotron beamline 8.3.1. Data were
indexed, integrated and scaled using HKL2000 [46] (Table 1).
The structure was determined using the AutoMR molecular
replacement program (PHENIX crystallographic suite) and
a model of the human apo Dlg3 PDZ2 domain (pdb accession
code 2FE5). One solution was found in the asymmetric unit. The
molecular replacement solution showed clear electron density for
the APC peptide. The model was built using AutoBuild (PHENIX)
[47] and refined iteratively through manual builds in Coot [48]
followed by refinement runs using phenix.refine (PHENIX) against
a maximum likelihood target function. Refinement statistics were
monitored using a Free R, calculated using 10% of the data,
randomly excluded from refinement. The final model includes one
Dlg1 PDZ2 molecule (chain A: residues 310–406, residue R310
modelled as alanine), one APC molecule (chain B: residues 2838–
2843), and 106 water molecules. Structure figures were produced
using PyMOL (http://pymol.sourceforge.net).
Data Deposition
Coordinates for the human Dlg1 PDZ2-APC complex have
been deposited in the Protein Data Bank under accession code:
4G69.
Results
Structure Determination of the Human Dlg1 PDZ2-APC
Complex
To examine the molecular basis for the Human Dlg1 PDZ2–
APC interaction, the Dlg1 PDZ2 domain (residues 310–407) was
purified and complexed with a peptide corresponding to the C-
terminal 11 residues of APC with an N-terminal TMR
fluorophore covalently bound. A 1:1.2 molar ratio of the PDZ
domain:APC peptide was used. Thin crystal plates grew over the
course of a week from a polyethylene glycol condition at pH 6.25.
Crystals were bright red compared to the surrounding solution,
indicative of peptide incorporation into the crystal. Diffraction
data was collected to a resolution of 2.0 Å and processed in the
space group P212121. A peptide-free human Dlg3 PDZ2 model
(SAP97, PDB code 2FE5) was used to find one molecule in the
asymmetric unit. Strong electron density was evident in the PDZ
peptide-binding site and the final six C-terminal residues of the
APC peptide could be assigned and built into the electron density.
The structure was built and refined to final R and Rfree factors of
17.1% and 18.3%, respectively. No electron density was evident
for the TMR fluorophore or the N-terminal five amino acids of the
APC peptide (Figure 1C). The full PDZ domain was modelled,
including residues 310–406.
Overall Architecture of the Dlg1 PDZ2-APC Complex
Dlg1 PDZ2 is a canonical PDZ domain fold (Figure 1C–F) [49].
A twisted, anti-parallel b-sheet establishes the core of the domain
and progresses through five b-strands: bA-bE-bD-bC-bB. The bB-
bC segment is connected to bD by a short, single turn helix, aA
that packs against bA, covering the hydrophobic core. A second
helix, aB, with its flanking loop regions, connects bD and bE. The
loop bridging bD and aB is packed between these structural
elements and runs anti-parallel to them. Collectively, the domain
forms a compact structure with an exposed, hydrophobic groove
framed by bB and aB as well as the extended bA-bB and bB-bC
loops. Nestled in the hydrophobic groove is the APC peptide in
a b-strand conformation, running anti-parallel to the adjacent bB




Cell dimensions: a,b,c (Å) 27.1, 51.2, 71.8
Resolution (Å) 70–2.00 (2.07–2.00)
Reflections: Measured/Unique 32635/6846
Completeness (%) 97.8 (82.9)





Resolution (Å) 29.4–2.00 (2.15–2.00)
Rb/Rfree (%)
c 17.1 (16.4)/18.3 (18.7)
Reflections: R/Rfree 6158/688
Total atoms: Protein/Water 769/106
Stereochemical ideality (rmsd): Bonds/
Angles (Å/u)
0.007/0.980




Parentheses list statistics for the high resolution shell
aRsym =g|Ii2,l.|/gI where Ii is the integrated intensity of the i-th observation
and,I.is the mean intensity of the reflections over Friedel and symmetry
equivalents.
bR value =g(|Fobs|2k|Fcalc|)/g|Fobs|.
cRfree is calculated using a 10% subset of the data that are removed randomly
from the original data and excluded from refinement.
doi:10.1371/journal.pone.0050097.t001
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strand and parallel to the aB helix. The APC C-terminal
carboxylate group is positioned proximal to the bA-bB loops.
Distal to this peptide-binding groove, the PDZ domain’s N- and
C-termini are positioned next to one another.
Species- and Dlg Isoform-specific Conserved Rims Frame
the APC Binding Site
To investigate specificity in the Dlg1 PDZ2-APC interaction, I
aligned Dlg1 PDZ2 domains from diverse species with human
Dlg1 PDZ1-3 and Dlg2-4 PDZ2. Invariance was mapped with
three criteria: those residues invariant across all PDZ domains
aligned, those residues invariant across Dlg1 PDZ2 domains
aligned, and those residues invariant across Dlg1 PDZ2 domains
aligned but different in Drosophila Dlg1 PDZ2 (Figure 2A).
Drosophila was set as a point of divergence given that Drosophila
APC does not contain a C-terminal PDZ-binding motif. An
alignment of APC C-terminal sequences from the same set of
species used in the Dlg alignment is presented in Figure 2B. In
contrast to Drosophila APC, all other species aligned ranging from
human to pufferfish (Tetraodon nigroviridis) are invariant across seven
of the ultimate eight APC residues, conforming to a type I PDZ
binding motif (Figure 2B). When the three contours of Dlg PDZ
invariance are mapped on the Dlg1 PDZ2-APC complex, a core
set of residues, invariant across all PDZ domains aligned, is
positioned in the peptide binding groove to mediate canonical
PDZ-type I peptide interactions (Figure 2C, green) [49]. A
signature, invariant PDZ motif: GLGF, underlies this site and
forms contacts with the ultimate three APC residues, including the
carboxylate group. Surrounding the groove are residues positioned
at the peptide’s N- and C-termini that are invariant across all Dlg1
PDZ2 species aligned, including Drosophila (Figure 2C, yellow).
However, flanking either side of the APC b-strand are residues
invariant across the Dlg1 PDZ2 members aligned, except
Drosophila (Figure 2C, orange). A number of these residues are
also present in other human Dlg PDZ domains, including the Dlg1
PDZ1 domain that also exhibits APC C-terminus binding activity
in vitro. Many of these invariant residues reside on the aB helix and
are APC peptide binding determinants while others flank the
peptide binding site, but are not directly involved in peptide
binding. Overall, a collective, invariant site is defined by Dlg PDZ
domains from species that contain the C-terminal APC sequence
GSYQVTSV, where Q is a hydrophobic residue. While some of
these residues are APC-binding determinants, flanking peripheral
residues, along with the bound APC molecule, may define
a composite Dlg1 PDZ2-APC binding site for other factors
involved in Dlg1 scaffolding.
The Dlg1 PDZ2-APC Binding Determinants
The APC C-terminal peptide lies in the PDZ type I-specific
furrow defined by bB and aB. The APC peptide forms a b-strand
that makes a canonical hydrogen bond network with the anti-
parallel bB strand (Figure 3A–C). The ultimate three APC
residues: TSV, conform to the type I PDZ peptide motif: S/T-X-
Q, and make standard contacts in the furrow. Specifically, the APC
V2843 carboxylate group makes hydrogen bonds with the
backbone amides of L329, G330, and F331 (Figure 3A,B). The
APC V2843 side chain packs in the hydrophobic core of the
furrow, making van der Waals contacts with L329, F331, and
L391. The APC T2841 side chain hydroxyl makes a hydrogen
bond to the H384 ring Ne while the T2841 Cb and Cc atoms
make van der Waals contacts with I333 and V388 respectively
(Figure 3C). While the ultimate APC residues conform to standard
type-I PDZ interactions, the penultimate three APC residues:
YLV, also engage the Dlg1 PDZ2 peptide binding furrow and
make specific contacts with Dlg1. V2840 contributes to the anti-
parallel b-strand interaction while the backbone spanning APC
Y2838 and L2839 is stabilized by a hydrogen bonding network
with the Dlg1 N339 carboxamide group (Figure 3C). APC L2839
and V2840 also make van der Waals contacts with Dlg1 residues
H384 and A334 respectively. Collectively, Dlg1 PDZ2 and the
APC peptide bury 744 Å2 of solvent accessible surface area.
PDZ Domain Plasticity and Conformational Change
To investigate conformational change that occurs upon APC
peptide binding, the Dlg1-PDZ2-APC structure was superimposed
on the apo structure of human Dlg1 PDZ2 (Figure 3D) [50].
Distinct structural differences are noted in the peptide-binding
cleft. In the apo structure, aB is closer to the bB strand than in the
APC-bound structure, indicative that the peptide-binding cleft
splays to allow APC access and binding. Structural changes in the
APC-bound structure are also evident in the loop regions that
flank the peptide binding site, these include the aB-bE loop, the
bA-bB loop, as well as distal structural elements including the bC-
aA loop which is shifted away from the peptide binding site,
potentially through movement in the adjacent bA-bB loop.
Comparative B-factor analysis for the apo and APC-bound
PDZ2 structures show relatively high B-factors in regions that
correlate with structural changes between the two states
(Figure 3D–F). Normalizing the B-factor range for the two
structures, the bB strand and the aB helix displayed very low B-
factors in the Dlg1 PDZ2-APC structure in contrast to the Dlg1
PDZ2 apo structure where the highest B-factors mapped to the aB
helix and the flanking loops. This indicates that the aB helix is
moderately mobile and becomes stabilized once the APC peptide
engages the furrow.
High-occupancy Conformation of the APC C-terminal
Region
Recent work by Zhang et al. analyzing the structure and
binding mode of Dlg1 with APC determined a significantly
different structural engagement between Dlg1 PDZ2 and APC
[26]. This crystal structure, determined in space group P21,
contained five Dlg1 PDZ2 molecules in the asymmetric unit, of
which only one PDZ molecule showed electron density into which
an APC peptide could be modelled. In contrast, the structure
presented here, determined in space group P212121, contains
a single Dlg1 PDZ2 molecule in the asymmetric unit, with a fully-
bound, APC C-terminal peptide (Figure 4A). When the Dlg1
PDZ2-APC complex by Zhang et al. is compared to the structure
presented here as well as the Dlg1 PDZ2 apo structure, the
orientation of the APC peptide and the PDZ peptide binding
furrow adopt highly different conformations (Figure 4B, orange
arrows). First, the APC peptide in the current structure docks
along the entire PDZ peptide-binding furrow, forming an
extensive hydrogen bonding network with Dlg1 PDZ2, extending
the PDZ b-sheet through anti-parallel strand extension and
burying 372 Å2 of the peptide’s solvent accessible surface area.
In contrast, the APC C-terminal peptide in the Zhang et al.
structure only engages the PDZ furrow using its C-terminal four
residues. Between the two structures, the ultimate C-terminal
residue, V2843, is positioned in the furrow equivalently. However,
every preceding APC residue in the Zhang et al. structure adopts
a significantly different spatial conformation in regard to both the
backbone position as well as side chain rotamer conformation. In
the Zhang et al. structure, the APC peptide N-terminal region is
displaced from the PDZ domain, splayed nearly 45u from the PDZ
domain leaving only the ultimate four APC residues to bind Dlg1
PDZ2 (Figure 4A–C). This contrasts with the ultimate six APC
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residues that engage Dlg1 PDZ2 in the structure reported here.
The two structures also differ with regard to the conformation of
the PDZ domain’s peptide-binding furrow. In the Zhang et al.
structure, the Dlg1 PDZ peptide-binding furrow is structurally
more akin to the peptide-free Dlg1 PDZ2 apo structure, where aB
is positioned closer to bB, clamping the peptide furrow (Figure 4B)
[50]. In the Dlg1 PDZ2-APC structure presented here, aB is
displaced, opening the PDZ peptide-binding furrow, enabling
APC to bind the length of the furrow. Collectively, the differential
binding states observed in the two Dlg1 PDZ2-APC structures
likely reflect steps along a binding pathway: initial binding via
canonical interactions between the ultimate C-terminal valine and
the PDZ domain as observed in the Zhang et al. structure,
followed by docking of the N-terminal residues into the furrow and
displacement of the aB helix as observed in the structure reported
here.
Zhang et al. predicted that APC interacted with the PDZ2 bB-
bC loop, though an interaction was not observed in their structure
[26]. This prediction was based on isothermal titration calorimetry
experiments in which comparative binding affinities between the
APC peptide and Dlg1 PDZ1 and PDZ2 were measured. The
APC-PDZ1 Kd was measured to be 18.2+/27.6 mM, while the
APC-PDZ2 Kd was measured to be 1.05+/20.22 mM. Zhang
et al. hypothesized that the different affinities between APC and
the two PDZ domains could be due to sequence differences in the
respective bB-bC loops (Figure 2A). A glutamine resides at
position 340 in PDZ2, while the equivalent residue in PDZ1 is
a proline. When Zhang et al. made the PDZ2 Q340P mutation,
Figure 2. The Dlg1 PDZ2 peptide-binding cleft is highly conserved. A) Alignment of PDZ domains from human Dlg1 as well as PDZ2 from
human Dlg2-4 and Dlg1 from Sus scrofa (Ss), Rattus norvegicus (Rn), Mus musculus (Mm), Xenopus tropicalis (Xt), Anolis carolinensis (Ac), Danio rerio
(Dr), Tetraodon nigroviridis (Tn), and Drosophila melanogaster (Dm). Only a partial sequence was available for Tn, thus residue numbers are not listed.
The alignment was generated manually through analysis of conserved residues. Solvent accessible surface area for each residue in the Dlg1 PDZ2-
APC complex is indicated above the alignment as is secondary structure. Residues numbers above the alignment are for human Dlg1 PDZ2. Red
asterisks indicate the two sites commonly used to classify PDZ domains. Dlg1 PDZ2 residues that contact APC are indicated. Residues invariant across
all PDZ domains are colored green. Residues invariant across all Dlg1 PDZ domains are colored yellow. Residues invariant across all Dlg1 PDZ2
domains except Drosophila are colored orange. B) Alignment of APC C-terminal 21 amino acids for species aligned in A. The alignment was generated
manually through analysis of conserved residues. Residues invariant across all species except Drosophila are colored purple. Solvent accessible
surface area, secondary structure, and residues that contact Dlg1 PDZ2 are indicated. C) Structure of the Dlg1 PDZ2-APC complex with Dlg1 PDZ2
shown in spherical format and the APC peptide shown in stick format. Invariance is colored according to the alignments in A and B. The ribbon model
shown in inset is in the same orientation as the adjacent spherical model. The two spherical models are related by a 180u rotation about the y-axis.
doi:10.1371/journal.pone.0050097.g002
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the affinity for the APC peptide decreased, with a Kd equal to
9.80+/21.11 mM, implicating a role for the bB-bC loop in the
PDZ2-APC interaction. In the structure reported here, Q340
stabilizes the bB-bC loop, using its side chain to form hydrogen
bonds with the G344 backbone amide and the N346 side chain
(Figure 4D). The order Q340 confers to the bB-bC loop orients
the N339 side chain towards the APC peptide, promoting its
hydrogen bonding to the APC V2840 backbone amide and
carbonyl. Additionally, the Q340 and N339 backbone carbonyls
are oriented to interact with the APC Y2838 backbone. A proline
substitution at residue 340 would prohibit these backbone
interactions and restrict the ability of N339 to engage the APC
peptide, thereby resulting in decreased affinity for APC. Dlg1
PDZ1 has a lower affinity for APC than Dlg1 PDZ2, and
differences in the bB-bC loop may underlie this differential. The
conformation of the APC peptide bound to Dlg1 PDZ1, also
reported by Zhang et al., is similar to the APC peptide
conformation observed in the structure reported here, bound to
Dlg1 PDZ2 (Figure 4E) [26]. Differences in the orientation of the
L2839 side chain are evident, as is a shift in the ultimate residue,
V2843, emphasized by a positional change in the carboxylate
group. The APC carboxylate group is closer to the bA-bB loop
GLGF binding motif in the PDZ2 structure reported here than in
the Dlg1 PDZ1-APC structure. A residue that may underlie this
structural difference is the lysine residue K324 in the PDZ2 bA-bB
loop, which is an arginine, R229, in PDZ1. The arginine
guanidinium group alters the peptide-binding pocket in the
vicinity of the APC carboxylate group, effectively drawing the
APC peptide away from the PDZ1 GLGF motif. These conserved
Figure 3. The Dlg1 PDZ2 domain binds core, conserved determinants in the APC C-terminus. A) Interaction matrix between Dlg1 PDZ2
(y-axis) and the APC C-terminal peptide (x-axis). Residue number and the corresponding secondary structure are indicated along the axes.
Interactions (hydrogen bonds, salt bridges, and van der Waals) are contoured at a 4.5 Å cut-off. B, C) Stick model of the Dlg1 PDZ2-APC binding site.
Dlg1 PDZ2 and APC are colored as in Fig. 1C. Hydrogen bonds involved in the Dlg1 PDZ2-APC interaction are indicated with dashed lines. D)
Alignment of the Dlg1 PDZ2-APC structure (colored as in Fig. 1C) and the apo hDlg1 PDZ2 structure (grey, 98% sequence identity, includes I342W and
C378A mutations outside the peptide binding region, engineered for measuring protein folding, PDB code 2X7Z [50]), highlighting outward
movement in the aB helix. Orange arrows highlight structural differences. E, F) Comparative B-factor analysis of the apo Dlg1 PDZ2 structure and the
Dlg1 PDZ2-APC structure aligned in D. Ca B-factor ranges are color-coded according to the key below each molecule.
doi:10.1371/journal.pone.0050097.g003
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differences between Dlg1 PDZ1 and PDZ2, likely explain the
domains’ differential affinities for APC.
Ligand-dependent PDZ Clustering
PDZ domain-containing proteins, including the MAGUK
family, often have PDZ domain arrays. In Dlg1, PDZ1 and
Figure 4. Differential APC peptide binding correlates with PDZ domain conformation change. A) The Dlg1 PDZ2-APC structure
determined in this study with the PDZ2 domain shown in surface representation and colored green, APC peptide shown in stick format and colored
grey. Superimposed is the structure of the APC peptide bound to Dlg1 PDZ2 as determined by Zhang et al. (PDB code 3RL8 [26]). The 3RL8 APC
peptide is shown in stick format and colored cyan; the PDZ2 domain is not shown for simplicity. B) Ribbon diagram of the Dlg1 PDZ2-APC complex
determined in this study (Dlg1 PDZ2 in green, APC in grey), with the structure of the Dlg1 PDZ2-APC complex determined by Zhang et al. (Dlg1 PDZ2
in slate, APC peptide in cyan, PDB code 3RL8) and the apo Dlg1 PDZ2 structure (grey, PDB code 2X7Z [50]) superimposed. The conformation of the
Dlg1 PDZ2 domain bound to APC determined by Zhang et al. is more homologous to the Dlg1 PDZ2 apo structure than to the Dlg1 PDZ2-APC
structure determined in this study, specifically in the positioning of aB and the bC-aA loop that move outward from the peptide binding cleft upon
APC binding. Conformational differences between the PDZ domains and the APC peptides are highlighted by orange arrows. C) Comparison of the
APC peptide bound to Dlg1 PDZ2 from Zhang et al. versus this study, oriented as shown in A. The structure of the APC peptide determined in this
study use all residues shown to bind the Dlg1 PDZ2 structure. Significant repositioning occurs over residues L2839-T2841 as well as the side chain
rotamer positioning of S2842. D) Zoom view of the APC peptide N-terminal region and its interaction with the bB-bC loop. APC and Dlg1 PDZ2 are
shown in stick format, colored as in Figure 1C. The backbone region of APC V2840 is stabilized by hydrogen bonds with the N339 side chain. Specific
hydrogen bonds are shown as dashed lines. E) Orientation of the APC peptide bound to Dlg1 PDZ2 determined in this study (shown in grey, stick
format) versus the APC peptide structure bound to Dlg1 PDZ1, chain J, determined by Zhang et al. (PDB code 3RL7 [26]), colored purple and shown
in stick format. APC peptides are shown alone, positioned after structurally aligning the respective PDZ domains they are bound to (not shown).
doi:10.1371/journal.pone.0050097.g004
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PDZ2 are immediately adjoined in sequence, while PDZ3 is
separated from PDZ2 by a 49 amino acid linker. Studies
investigating the spatial arrangement of PDZ domains have
observed distinct structural states between tandem PDZ domains,
with changes inherent upon peptide binding
[16,17,18,19,20,21,22]. To investigate potential higher order
PDZ-PDZ interactions, I examined the symmetry mate interac-
tions in the P212121 crystal lattice. Dlg1 PDZ2-APC forms an
extensive interaction with a symmetry-related complex utilizing
the APC peptide in one complex as a prime binding-determinant.
The N-terminal PDZ2 bA strand from a symmetry mate binds
along the length of the neighbouring APC peptide (Figure 5). This
interaction between symmetry mates may mimic ligand-dependent
PDZ clustering interactions in MAGUK proteins. Because PDZ1
and PDZ2 are immediately adjoined in sequence, the observed
symmetry mate interaction would not be possible between PDZ1
and PDZ2 given the location of their respective C- and N-termini.
However, the linker that spans PDZ2 and PDZ3 would enable
these PDZ domains to potentially cluster via a ligand-dependent
interaction as observed here.
Discussion
Dlg1 PDZ2 conforms to a common G–H class PDZ domain
(G335, H384) with class I peptide-binding activity [15]. The APC
C-terminal sequence YLVTSV is a type I sequence (S/T-x-Q) that
engages the bB - aB furrow, forming standard hydrogen bonds
between the APC C-terminal carboxylate group and the backbone
amides of the bA-bB loop while the ultimate APC side chain packs
against hydrophobic residues in the PDZ furrow: L329, F331 and
L391. Comparison of the Dlg1 PDZ2-APC complexes determined
here and by Zhang et al. provide insight into binding plasticity and
potential pathways involved in binding [26]. In the Zhang et al.
structure, the APC peptide engages PDZ with its ultimate four
residues while the preceding two residues are splayed away from
the PDZ domain in a bent conformation (Figure 4C). When
compared to the structure presented here which is more akin to
a straight peptide conformation, only the ultimate APC valine
residues align. All other residues are positioned in different
rotamer conformations and the backbone of the two APC peptides
are angled 45u relative to one another (Figure 4C). The structure
of the APC peptide bound to PDZ2 reported here, conforms more
to the peptide arrangement observed in the Dlg1 PDZ1-APC
structure determined by Zhang et al. (Figure 4E) [26]. The
difference between the two Dlg1 PDZ2-APC structures may reflect
sequential binding steps. The Zhang et al. structure may represent
an initial binding mode delineated by an interaction between the
ultimate APC valine residue and the PDZ domain. This initial
interaction may then transit to a higher-order engagement as
additional conserved APC residues bind the PDZ2 bB-aB furrow
and the bB-bC loop. These dual structural states support the
previous observation of a sequential binding mechanism for the
Dlg PDZ2 domain [51]. The straight APC conformation reported
here and the additional PDZ2 contacts observed in that
conformation may reflect a higher-affinity bound state. In support,
the conformation affirms a prediction posed by Zhang et al. that
the APC peptide would make additional contacts with the bB-bC
loop based on the reduced affinity a PDZ2 bB-bC loop mutant
had for APC peptide binding [26]. In addition, the straight APC
peptide conformation observed in our structure is highly similar to
the straight conformation observed in the Dlg1 PDZ1-APC
structure, also determined by Zhang et al. [26]. Finally, the
conformation of the PDZ-binding furrow in the Zhang et al. Dlg1-
PDZ2-APC structure is more homologous to the closed state
observed in the peptide-free Dlg1 PDZ2 apo structure, while the
PDZ2 peptide furrow in the complex reported here is opened and
engages additional determinants on the APC peptide.
How PDZ arrays regulate protein-protein interactions by
sensing and clustering the proteins they interact with has remained
Figure 5. The Dlg1 PDZ2-APC complex mediates ligand-dependent interactions with a Dlg PDZ2 symmetry mate. Ribbon diagram of
the Dlg1 PDZ2-APC complex with one complex colored as in Fig. 1C and a crystal symmetry mate colored with Dlg1 PDZ2 b-strands in cyan, helices
aA and aB in teal and purple, and loops in dark blue. The Dlg1 PDZ2 symmetry mate uses its N-terminal loop and bA strand to interact with the APC
peptide from the symmetry mate, potentially reflecting a ligand-dependent PDZ clustering mechanism.
doi:10.1371/journal.pone.0050097.g005
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an outstanding question. To investigate how PDZ domains might
promote interactions between bound targets, I investigated
whether residues that line the PDZ binding furrow are conserved
with the hypothesis that a peptide-bound PDZ domain could form
a composite binding site for protein-protein interactions. Across
Dlg PDZ domains, core residues that line the peptide-binding
furrow, involved in peptide binding, are conserved. Surrounding
this region is a rim of conserved residues specific to Dlg1-PDZ2,
flanked by conserved regions specific to species whose APC
protein conforms to the invariant ultimate sequence GSYQVTSV.
These concentric, conserved sub-regions are unique to the peptide
binding face of the PDZ domain and are not maintained on the
non-peptide binding face. These residues may support the
architecture of the binding furrow, and/or they may act with
the bound peptide to form a composite binding site. PDZ intra-
molecular interactions have been observed to change, dependent
on the presence or absence of bound peptide. Whether APC-
bound PDZ2 forms a composite binding site for other PDZ
domains and/or their binding partners warrants further in-
vestigation. Potential insight into peptide-dependent PDZ cluster-
ing comes from observed crystal packing interactions between
symmetry mates in which the bA strand in a neighboring PDZ2
domain interacts with the APC peptide in an anti-parallel
orientation.
The interaction observed between Dlg1 PDZ2 and APC
facilitates a link between a cortical polarity determinant and the
APC signaling scaffold. APC can interact directly with the
microtubule cytoskeleton through a C-terminal basic region, or
indirectly through its C-terminal EB1 SxIP binding motif that
confers EB1-dependent APC microtubule plus end tracking
activity [40,41,42]. It is of note that the EB1 binding site and
the PDZ binding site are proximal to one another, separated by 30
amino acids. Whether there is structural communication between
these two sites remains to be determined. Collectively, the
structure presented here highlights the molecular determinants
that mediate the Dlg1 PDZ2-APC interaction and facilitate stable,
polarized microtubule attachment to a cortical polarity determi-
nant and contribute to the molecular bases that underlie directed
cell migration [6,52].
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